Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2026)

Adaptive Biotechnologies has disclosed Retained Earnings across 9 years of filings, most recently posting $1.6 billion for Q2 2026.

• In Q2 2026, Retained Earnings rose 1.78% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (up 1.78% YoY), while the FY2025 annual figure was $1.6 billion, up 5.01% from the prior year.
• Retained Earnings came in at $1.6 billion for Q2 2026 at Adaptive Biotechnologies, down from $1.6 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.6 billion in Q1 2026 to a low of $1.3 billion in Q1 2022.
• Average Retained Earnings over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2024.
• Year-over-year, Retained Earnings increased 5.01% in 2025 and gained 1.78% in 2026.
• Over 5 years, Retained Earnings stood at $1.4 billion in 2022, then gained by 4.7% to $1.5 billion in 2023, then grew by 3.71% to $1.5 billion in 2024, then climbed by 5.01% to $1.6 billion in 2025, then declined by 0.99% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $1.6 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.